SV Health Investors

United States
cb
Firm Location:United States • Boston, Massachusetts • Cambridge, Massachusetts • San Mateo, California • London • Burlingame, California • San Francisco Bay Area • United Kingdom
Investor Firms That Co-Invest with SV Health Investors
SOSVAtlas VentureBain Capital VenturesSummit PartnersPolaris PartnersAisling CapitalNovartis Venture FundJuxtapose CapitalB Capital Group7wire VenturesRA Capital ManagementSection 32U.S. Venture Partners (USVP)Lightstone VenturesThird Rock VenturesAbingworthAscension VenturesSandbox IndustriesNew Leaf Venture PartnersLevensohn Venture PartnersNovo VenturesJmi EquitySanofi VenturesOmega FundsBorealis VenturesM Ventures (Merck)EQT Life SciencesSilversmith Capital PartnersMcKesson VenturesOrbiMed AdvisorsPivotal Life SciencesSofinnova PartnersSan Diego SymphonySV Health Investors' Dementia Discovery Fund (DDF)Nan Fung Life SciencesS.R. One Ltd
SV Health Investors Team
Photo of Houman Ashrafian, Managing Partner at SV Health Investors
Houman Ashrafian
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in London (Other Lists)
to see your intro paths to Houman
Photo of Alex Badamchi-Zadeh, Senior Associate at SV Health Investors
Alex Badamchi-Zadeh
SV Health Investors·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)
to see your intro paths to Alex
Photo of Josh Baker, Analyst at SV Health Investors
Josh Baker
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to Josh
Photo of Michael Balmuth, Managing Partner at SV Health Investors
Michael Balmuth
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Michael
Photo of Jonathan Behr, Partner at SV Health Investors
Jonathan Behr
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
to see your intro paths to Jonathan
Photo of Kate Bingham, Managing Partner at SV Health Investors
Kate Bingham
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $30K - $3.0M
Investors in London
to see your intro paths to Kate
Photo of Darren Black, Partner at SV Health Investors
Darren Black
Sweet spot: $20.0M
Range: $5.0M - $50.0M
Investors in Boston (MA)
to see your intro paths to Darren
Photo of Rebecca Canter, Associate at SV Health Investors
Rebecca Canter
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
to see your intro paths to Rebecca
Photo of Charles Dunn, Principal at SV Health Investors
Charles Dunn
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom, Investors in London
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in London (Other Lists)
to see your intro paths to Charles
Photo of Tom Flynn, Managing Partner at SV Health Investors
Tom Flynn
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to Tom
Photo of Emily Gaudiano, Senior Associate at SV Health Investors
Emily Gaudiano
SV Health Investors·Senior Associate
Sweet spot: $25.0M
Range: $1M - $150.0M
Investors in United States
to see your intro paths to Emily
Photo of Miles Gerson, General Partner at SV Health Investors
Miles Gerson
SV Health Investors·General Partner
Sweet spot: $2.5M
Range: $1M - $5.0M
Investors in Cambridge (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Miles
EH
Eugene Hill
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston / New England, Investors in Boston (MA)
to see your intro paths to Eugene
Photo of Ash Khanna, Principal at SV Health Investors
Ash Khanna
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed)
to see your intro paths to Ash
Photo of Dirk Landgraf, Principal at SV Health Investors
Dirk Landgraf
Sweet spot: $5.0M
Range: $1M - $10.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Diverse Investors (Other Lists), Investors in Therapeutics (Series B), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in Therapeutics (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Dirk
Photo of Paul LaViolette, Managing Partner at SV Health Investors
Paul LaViolette
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Paul
Photo of Greg Madden, Managing Partner at SV Health Investors
Greg Madden
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diverse Investors (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Greg
Photo of Niyoshi Patel, Associate at SV Health Investors
Niyoshi Patel
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to Niyoshi
Photo of Mike Ross, Partner at SV Health Investors
Mike Ross
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States, Investors in SF Bay Area (CA), Investors in San Francisco (CA), Investors in San Mateo (CA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B)
to see your intro paths to Mike
Photo of Charles Warden, General Partner at SV Health Investors
Charles Warden
SV Health Investors·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
to see your intro paths to Charles